Cassileth PA - Search Results

1

Autologous bone marrow transplant in acute myeloid leukemia in first remission.

Cassileth PA, Andersen J, Lazarus HM, Colvin OM, Bennett JM, Stadtmauer EA, Kaizer H, Weiner RS, Edelstein M, Oken MM. Cassileth PA, et al. J Clin Oncol. 1993 Feb;11(2):314-9. doi: 10.1200/JCO.1993.11.2.314. J Clin Oncol. 1993. PMID: 8426209

2

Attenuated high-dose cytosine arabinoside in the treatment of the elderly patient with acute nonlymphocytic leukemia. An Eastern Cooperative Oncology Group Pilot Study.

Kahn SB, Ebrahim K, Cassileth P, Bennett JM, Knospe WH, O'Connell MJ. Kahn SB, et al. Am J Clin Oncol. 1989 Jun;12(3):201-4. doi: 10.1097/00000421-198906000-00004. Am J Clin Oncol. 1989. PMID: 2729177

3

A critical comparison of allogeneic bone marrow transplantation and conventional chemotherapy as treatment for acute nonlymphocytic leukemia.

Begg CB, McGlave PB, Bennett JM, Cassileth PA, Oken MM. Begg CB, et al. Among authors: cassileth pa. J Clin Oncol. 1984 May;2(5):369-78. doi: 10.1200/JCO.1984.2.5.369. J Clin Oncol. 1984. PMID: 6374048 Clinical Trial.

4

A phase II trial of VP 16-213 in adults with refractory acute myeloid leukemia. An Eastern Cooperative Oncology Group study.

Bennett JM, Lymann GH, Cassileth PA, Glick JH, Oken MM. Bennett JM, et al. Among authors: cassileth pa. Am J Clin Oncol. 1984 Oct;7(5):471-3. doi: 10.1097/00000421-198410000-00015. Am J Clin Oncol. 1984. PMID: 6594926 Clinical Trial.

5

Etoposide in leukemia, lymphoma and bone marrow transplantation.

Stadtmauer EA, Cassileth PA, Gale RP. Stadtmauer EA, et al. Among authors: cassileth pa. Leuk Res. 1989;13(8):639-50. doi: 10.1016/0145-2126(89)90052-0. Leuk Res. 1989. PMID: 2677526 Review.

6

Varying intensity of postremission therapy in acute myeloid leukemia.

Cassileth PA, Lynch E, Hines JD, Oken MM, Mazza JJ, Bennett JM, McGlave PB, Edelstein M, Harrington DP, O'Connell MJ. Cassileth PA, et al. Blood. 1992 Apr 15;79(8):1924-30. Blood. 1992. PMID: 1562720 Free article. Clinical Trial.

7

Pentostatin induces durable remissions in hairy cell leukemia.

Cassileth PA, Cheuvart B, Spiers AS, Harrington DP, Cummings FJ, Neiman RS, Bennett JM, O'Connell MJ. Cassileth PA, et al. J Clin Oncol. 1991 Feb;9(2):243-6. doi: 10.1200/JCO.1991.9.2.243. J Clin Oncol. 1991. PMID: 1988572

8

Comparison of postremission therapies in adult acute myeloid leukemia: preliminary analysis of an ECOG study. Eastern Cooperative Oncology Group.

Cassileth PA, Harrington DP, Hines JD, Oken MM, Mazza JJ, McGlave P, Bennett JM, Lynch E, O'Connell MJ. Cassileth PA, et al. Haematol Blood Transfus. 1990;33:267-70. doi: 10.1007/978-3-642-74643-7_48. Haematol Blood Transfus. 1990. PMID: 2182420 Clinical Trial. No abstract available.

9

High peripheral blast count in adult acute myelogenous leukemia is a primary risk factor for CNS leukemia.

Cassileth PA, Sylvester LS, Bennett JM, Begg CB. Cassileth PA, et al. J Clin Oncol. 1988 Mar;6(3):495-8. doi: 10.1200/JCO.1988.6.3.495. J Clin Oncol. 1988. PMID: 3162514

10

Continuous infusion homoharringtonine (NSC 141633) in refractory acute nonlymphocytic leukemia. An ECOG pilot study.

Stewart JA, Cassileth PA, Bennett JM, O'Connell MJ. Stewart JA, et al. Among authors: cassileth pa. Am J Clin Oncol. 1988 Dec;11(6):627-9. doi: 10.1097/00000421-198812000-00006. Am J Clin Oncol. 1988. PMID: 3189228

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters